Insider · CIK 0001867173

Carr Douglas

Reports to the SEC for 1 company · PHILADELPHIA, PA

sec.gov

Transactions

Companies

Filings

CIK

0001867173

Forms 4 and 5

Insider transactions

37 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-14	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−1,658 sh	$1.93	−$3,199.94	502,907
2026-09-08	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−254 sh	$2.05	−$520.7	504,565
2026-08-03	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−275 sh	$1.98	−$543.675	504,819
2026-06-12	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−1,654 sh	$2.23	−$3,691.728	505,094
2026-06-08	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−249 sh	$2.11	−$525.639	506,748
2026-05-04	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−264 sh	$2.34	−$618.024	506,997
2026-03-12	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−7,043 sh	$2.55	−$18K	507,261
2026-03-09	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−247 sh	$2.54	−$626.392	514,304
2026-02-03	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−323 sh	$1.82	−$588.506	514,551
2026-02-02	IPSCCentury Therapeutics, Inc.A Award	SVP Finance & Operations	AAward	+110K sh	—	—	514,874
2026-02-02	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP Finance & Operations	AAward	+225K sh	—	—	225,000
2025-12-08	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−257 sh	$0.53	−$136.724	404,874
2025-11-03	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−292 sh	$0.59	−$171.112	405,131
2025-09-08	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−263 sh	$0.50	−$131.5	405,423
2025-08-04	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−296 sh	$0.53	−$158.064	405,686
2025-06-09	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−4,904 sh	$0.62	−$3,050.288	405,982
2025-05-05	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−295 sh	$0.55	−$162.25	410,886
2025-03-11	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP Finance & Operations	AAward	+95.6K sh	—	—	95,625
2025-03-11	IPSCCentury Therapeutics, Inc.A Award	SVP Finance & Operations	AAward	+95.6K sh	—	—	411,181
2025-03-10	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−1,240 sh	$0.61	−$762.6	315,556
2025-02-03	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−351 sh	$0.78	−$273.78	316,796
2024-11-04	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−283 sh	$1.23	−$347.241	317,147
2024-11-01	IPSCCentury Therapeutics, Inc.F Tax Payment	SVP Finance & Operations	FTax Payment	−16.6K sh	$1.26	−$20.9K	317,430
2024-08-05	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−289 sh	$1.83	−$528.003	334,041
2024-06-07	IPSCCentury Therapeutics, Inc.A Award	SVP Finance & Operations	AAward	+17K sh	—	—	334,330
2024-05-03	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−257 sh	$3.11	−$798.242	317,323
2024-03-07	IPSCCentury Therapeutics, Inc.A Award	SVP Finance & Operations	AAward	+14K sh	—	—	317,580
2024-03-07	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP Finance & Operations	AAward	+81K sh	—	—	81,000
2024-02-06	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−557 sh	$4.49	−$2,499.259	303,580
2024-02-05	IPSCCentury Therapeutics, Inc.S Sale	SVP Finance & Operations	SSale	−643 sh	$3.84	−$2,469.763	304,137
2023-11-01	IPSCCentury Therapeutics, Inc.F Tax Payment	SVP Finance & Operations	FTax Payment	−16.6K sh	$1.49	−$24.8K	304,780
2023-05-15	IPSCCentury Therapeutics, Inc.A Award	SVP Finance & Operations	AAward	+121K sh	—	—	321,391
2023-02-02	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP Finance & Operations	AAward	+45K sh	—	—	45,000
2023-02-02	IPSCCentury Therapeutics, Inc.A Award	SVP Finance & Operations	AAward	+7,500 sh	—	—	193,045
2023-02-02	IPSCCentury Therapeutics, Inc.A Award	SVP Finance & Operations	AAward	+7,500 sh	—	—	200,545
2023-02-02	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP Finance & Operations	AAward	+45K sh	—	—	45,000
2022-01-25	IPSCCentury Therapeutics, Inc. · Stock Option (right to buy)A Award	SVP Finance & Operations	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Sep 154
Carr Douglas0001867173-26-000020
SEC(opens sec.gov)
Sep 94
Carr Douglas0001867173-26-000018
SEC(opens sec.gov)
Aug 54
Carr Douglas0001867173-26-000016
SEC(opens sec.gov)
Jun 154
Carr Douglas0001867173-26-000014
SEC(opens sec.gov)
Jun 94
Carr Douglas0001867173-26-000012
SEC(opens sec.gov)
May 64
Carr Douglas0001867173-26-000010
SEC(opens sec.gov)
Mar 164
Carr Douglas0001867173-26-000008
SEC(opens sec.gov)
Mar 114
Carr Douglas0001867173-26-000006
SEC(opens sec.gov)
Feb 54
Carr Douglas0001867173-26-000004
SEC(opens sec.gov)
Feb 44
Carr Douglas0001867173-26-000002
SEC(opens sec.gov)
Dec 104
Carr Douglas0001867173-25-000005
SEC(opens sec.gov)
Nov 54
Carr Douglas0001867173-25-000003
SEC(opens sec.gov)
Sep 104
Carr Douglas0001062993-25-015526
SEC(opens sec.gov)
Aug 64
Carr Douglas0001062993-25-013720
SEC(opens sec.gov)
Jun 114
Carr Douglas0001062993-25-011429
SEC(opens sec.gov)
May 74
Carr Douglas0001062993-25-008772
SEC(opens sec.gov)
Mar 124
Carr Douglas0001062993-25-005288
SEC(opens sec.gov)

Companies

Century Therapeutics, Inc.SVP Finance & OperationsIPSC

Address

C/O CENTURY THERAPEUTICS, INC. 25 N 38TH STREET, 12TH FLOOR

PHILADELPHIA, PA, 19104